Table 3.

Relative frequency of diagnoses for the period 2005–14, compared with selected publications

Author	Present studya	Chiu et al. [23]	Polito et al. [24]	Hanko et al. [10]	Hou et al. [11]	Jegatheesan et al. [8]	Rychlik et al. [25]	Schena et al. [26]	Woo et al. [12]	Xu et al. [17]	Rivera et al. [27]	Wang et al. [15]
Land	Denmark	Taiwan	Brazil	UK	China	Australia	Czechoslovakia	Italy	Singapore	China	Spain	China
Publication date	2020	2018	2010	2009	2018	2016	2004	1997	2019	2016	2002	2019
Minimal change	8	19	12	11	12	5	10	6	20	5	12	12
Endocapillary	1	2	7		1	3	1	3		1
FSGS	12	22	19	4	8	19	9	10	25		16	5
Mesangioproliferative/IgAb	24	29	19	43	51	30	31	40	31	56	20	39
Membranous	12	21	16		15	12	8	17	15	12	16	13
Membranoproliferative	5	3	3	10	1	3	4	5		2	9
Extracapillary	4	5				12	3	4		1
AntiGBM	3						1	0.3
ANCAV	16		2				5	5			11
Proliferative	2		4
Focal	1									9
Lupus	11		16		11	13	8	9		7	14

^a2005–14.

^bIncluding Henoch–Schönlein.

Published figures adjusted for comparison. Figures in per cent.